Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-15

Clinical Trial Update: A Study to Observe the Safety, Tolerability, and Efficacy of Remodulin

View source ↗

Summary

This entry describes a planned clinical trial to evaluate the safety, tolerability, and efficacy of Remodulin (treprostinil) in people with Pulmonary Arterial H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remodulin (treprostinil)

Snippet

Sponsor: Excelsior | Conditions: Pulmonary Arterial Hypertension | Status: NOT_YET_RECRUITING